Literature DB >> 8976654

Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.

A Gianviti1, R S Trompeter, T M Barratt, M F Lythgoe, M J Dillon.   

Abstract

A retrospective study of 48 patients was conducted to evaluate the efficacy of plasma exchange in children with idiopathic rapidly progressive glomerulonephritis (IRPGN), and renal or non-renal vasculitis. All patients were followed up at a single centre over a 15 year period. Treatment consisted of corticosteroids and/or cytotoxic agents. Plasma exchange was used in all patients because of severe renal involvement and/or clinical deterioration. One hundred per cent of patients with renal vasculitis who started plasma exchange within one month of disease onset and 58% of cases with IRPGN had significant improvement in renal function. No relapses of vasculitis were observed after treatment with plasma exchange in patients with renal and non-renal vasculitis. The results suggest that plasma exchange associated with immunosuppressive treatment could be of benefit in cases of IRPGN or vasculitis in terms of both renal and extrarenal recovery.

Entities:  

Mesh:

Year:  1996        PMID: 8976654      PMCID: PMC1511700          DOI: 10.1136/adc.75.3.186

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  20 in total

1.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

2.  Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.

Authors:  C D Pusey; A J Rees; D J Evans; D K Peters; C M Lockwood
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

3.  Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.

Authors:  W M Glöckner; H G Sieberth; H E Wichmann; E Backes; R Bambauer; W H Boesken; A Bohle; A Daul; N Graben; F Keller
Journal:  Clin Nephrol       Date:  1988-01       Impact factor: 0.975

4.  Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.

Authors:  L Guillevin; B Jarrousse; C Lok; F Lhote; J P Jais; D Le Thi Huong Du; A Bussel
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

5.  The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura.

Authors:  J A Mills; B A Michel; D A Bloch; L H Calabrese; G G Hunder; W P Arend; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

6.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; S P Lan; R D Rohde; J M Lachin
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

7.  Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  M A Pohl; S P Lan; T Berl
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

8.  Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

Authors:  L Guillevin; O Fain; F Lhote; B Jarrousse; D Le Thi Huong; A Bussel; A Leon
Journal:  Arthritis Rheum       Date:  1992-02

9.  Plasma exchange improves the glomerulonephritis of systemic lupus erythematosus in selected pediatric patients.

Authors:  S C Jordan; W Ho; R Ettenger; I B Salusky; R N Fine
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.

Authors:  R W Lightfoot; B A Michel; D A Bloch; G G Hunder; N J Zvaifler; D J McShane; W P Arend; L H Calabrese; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
View more
  18 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

3.  Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.

Authors:  Zeynep Ozbalkan; Sedat Kiraz; M Akif Ozturk; A Ihsan Ertenli; Sule Apras; Meral Calguneri
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

Review 4.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

5.  Childhood vasculitis and plasma exchange.

Authors:  Elizabeth Wright; Michael J Dillon; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2006-08-17       Impact factor: 3.183

6.  The incidence and severity of IgA vasculitis with nephritis over a 10-year period in our hospital.

Authors:  Keishi Yamane; Yukihiko Kawasaki; Ryo Maeda; Shinichiro Ohara; Kazuhide Suyama; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2017-09-14

7.  Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement.

Authors:  J Rech; F Fuchs; S Kallert; A J Hueber; C Requadt; B Manger; J R Kalden; K Amann; R Strauss; H Schulze-Koops
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

Review 8.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.

Authors:  Roberta Fenoglio; Carla Naretto; Bruno Basolo; Giacomo Quattrocchio; Michela Ferro; Paola Mesiano; Giulietta Beltrame; Dario Roccatello
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

9.  Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Michihiko Murai; Ai Takahashi; Masato Isome; Ruriko Nozawa; Shigeo Suzuki; Hitoshi Suzuki
Journal:  Pediatr Nephrol       Date:  2004-06-09       Impact factor: 3.714

10.  The incidence and severity of Henoch-Schönlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Eichi Yugeta; Masahiko Katayose; Shigeo Suzuki; Hiroko Sakuma; Kenji Nemoto; Akira Tsukagoshi; Katsutoshi Nagasawa; Mitsuaki Hosoya
Journal:  Int Urol Nephrol       Date:  2010-01-10       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.